🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I am thrilled to share the Alzheimer’s Disease Drug Development Pipeline: 2025 with our fabulous colleague Jeffrey Cummings Very glad to see more diverse targets beyond anti-amyloid drugs. Looking forward pipeline 2026! Thanks The National Institute on Aging (NIA) alz-journals.onlinelibrary.wiley.com/doi/epdf/10.10…

nytimes.com/interactive/20…

Tim Hohman from Vanderbilt ADRC gave us a fantastic talk and amazing visit to our Genomic Medicine Institute in the last weekend. We discussed many ADSP collaborations and others, including big data and quantum computing!! Looking forward more and following up!!!

Earlier today, NIH Director Dr. Jay Bhattacharya affirmed his commitment to advancing progress in the fight against Alzheimer’s disease and other dementia during a Senate hearing on the FY26 NIH budget. Read our statement: bit.ly/45MOxwg.

I had a great time giving a keynote talk on multiomics integration for survival prediction to the MONET workshop at ColoradoSPH yesterday. coloradosph.cuanschutz.edu/research-and-p…

Cures Within Reach Cures Within Reach is now accepting submissions for Phase I or Phase IIA clinical trials to validate AI-driven drug repurposing opportunities in any unsolved disease! Chan Zuckerberg Initiative Eligible clinical trials must include AI-generated data as part of the preclinical

🎧 New AD/PD™ Session Spotlight out now! In this episode, Jeffrey Cummings breaks down the current state of the #Alzheimers disease drug development pipeline - from biomarker breakthroughs to emerging therapeutic targets and global trial trends. If you're involved in drug

🧬AlphaFold3 nails protein structure prediction ... except for 48% of the interactome 😅 PIONEER2.0 blends homology + DL to map interfaces for 352k human PPIs, beating AF3 where it falters.

138 drugs in the Alzheimer's pipeline 📈 - 9% growth from last year - 74% target the disease itself (not just symptoms) - 182 trials actively recruiting worldwide Key shift: We're moving BEYOND amyloid to 15 different disease targets. This is what progress looks like.

What if the next Alzheimer's breakthrough isn't a new drug - but an old one? Nature Communications reveals AI/ big data are uncovering surprising treatments for AD. - Diabetes drugs - Asthma meds - Even Viagra Here's what they're uncovering and why you aren't hearing about this 🧵

‼️Anyone interested in organ fibrosis please join us for the Keystone Fibrosis Symposium 2026 ‘Cross Organ Pathology and Pathways to Clinical Development’ ‼️Introduction video can be found here url.avanan.click/v2/r01/___http…. Registration 👉🏻 keysym.us/KSFibrosis26 Suzanne Devkota

Article covering a few key examples of how NIH funding cuts are affecting research on #Alzheimers disease: The social cost of federal cuts to Alzheimer’s research universityworldnews.com/post.php?story…

AI is mining big data to repurpose drugs. Early wins in blood disorders, and now hypothesis-generating candidates are emerging for Parkinson’s & Alzheimer’s. Feixiong Cheng @AANMember #NeuroTwitter hubs.la/Q03sT5zX0

The first Alzheimer’s Disease Golden Conference is happening now!! It is exciting to present our AD research in Wednesday and many networking and discussions with all amazing collaborators!!! grc.org/alzheimer-s-di… Thanks our co-chairs Towfique Raj Oliver Lichtarge The National Institute on Aging (NIA)

We are expanding Avon Hospital and the Richard E. Jacobs Family Health Center to meet the growing demand for care on Cleveland's west side. The project will nearly double the size of our campus in Avon. Learn more: cle.clinic/44mr1nC

I am excited to share new plans for a significant expansion of Cleveland Clinic's Avon campus. This is an example of our commitment to reinvesting in our mission to serve more patients and meet the unique needs of our communities. Read More: bit.ly/45Gjp1t

Fantastic AI/ML session is happening now at the AD Golden Conference presenting by Ryan Corces David A Knowles (@davidaknowles.bsky.social) Dr. Steven Finkbeiner and other fabulous speakers. Thanks Towfique Raj and Dr. Olivier Lichtarge for this well-organized Golden conference!!

55 hours of sciencing … and that’s a wrap. 🧠

🔥 Literally hot off the press 🔥 Such an honor to have proposed this textbook & serve as Editor! What a pleasure working with Elsevier Elsevier | Scopus Elsevier | ScienceDirect and so many incredible #CardioOnc authors, who are colleagues, mentees, friends, leaders, sponsors & mentors 🤩

Researchers at McMaster University, Cleveland Clinic & Case Comprehensive Cancer Center (Case Comp Cancer Ctr) have uncovered how a protein long associated with Alzheimer’s disease helps lung cancer spread to the brain - a discovery that provides hope for potential treatment. ow.ly/P3i250Wl2IJ